Fluicell

Fluicell EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Fluicell (FLUI.ST) as of Oct 17, 2026 is -47.01 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -62.11 % — a change of -24.31% (higher).

EBIT/Assets

-47.01 %

YoY

-24.31%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Fluicell is 2025 -47.01 % . Operating Income to Assets Ratio (EBIT/Assets) of Fluicell was 2024 -62.11 % . It decreases by -24.31% higher compared to the previous year.

The Fluicell EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-56.90 SEK
Jan 1, 2019
-93.71 SEK
Jan 1, 2020
-68.57 SEK
Jan 1, 2021
-80.41 SEK
Jan 1, 2022
-68.40 SEK
Jan 1, 2023
-287.78 SEK
Jan 1, 2024
-62.11 SEK
Jan 1, 2025
-47.01 SEK
The Fluicell EBIT/Assets history
YEAREBIT/AssetsYoY
-47.01 %-24.31%
-62.11 %-78.42%
-287.78 %+320.75%
-68.40 %-14.94%
-80.41 %+17.26%
-68.57 %-26.83%
-93.71 %+64.70%
-56.90 %-11.74%
-64.46 %-63.98%
-178.95 %-20.68%
-225.62 %+130.46%
-97.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluicell Stock analysis

What does Fluicell do? Fluicell AB is a health care company headquartered in Moelndal, Sweden. It provides fluid platforms for multi-functional pipettes used in cell-based pharmacology research. The company commercializes products including the BioPen and Dynaflow Resolve for processing and studying individual cells, primarily in drug development. It also develops bioprinting technology called Biopixlar Retina, which creates complex tissue-like structures with control over individual cell positioning in both 2D and 3D formats. Fluicell AB completed its IPO on April 18, 2018. Fluicell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluicell stock

Operating Income to Assets Ratio (EBIT/Assets) of Fluicell is -47.01 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Fluicell changed from -62.11 % to -47.01 %, representing a -24.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Fluicell since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Fluicell with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Fluicell

All Key Metrics — Fluicell